Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors

Published:2013-05-31 Issue:16 Volume:56 Page:6279-6296
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Galli Ubaldina¹,Travelli Cristina¹,Massarotti Alberto¹,Fakhfouri Gohar²,Rahimian Reza³,Tron Gian Cesare¹,Genazzani Armando A.¹

Affiliation:

1. Dipartimento di Scienze del Farmaco, Università degli Studi del Piemonte Orientale “A. Avogadro”, Largo Donegani 2, 28100 Novara, Italy

2. Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3. Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm4001049

Reference122 articles.

1. Targeting cancer metabolism: a therapeutic window opens

2. Nampt: linking NAD biology, metabolism and cancer

3. The Nicotinamide Phosphoribosyltransferase: A Molecular Link between Metabolism, Inflammation, and Cancer: Figure 1.

4. The Pyridine Nucleotide Cycle

5. The biosynthesis and turnover of nicotinamide adenine dinucleotide in enucleated culture cells

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Analogues of the Nicotinamide Phosphoribosyltransferase Inhibitor FK866 as Potential Anti-Pancreatic Cancer Agents;Medicinal Chemistry;2024-08

2. Dual-targeted NAMPT inhibitors as a progressive strategy for cancer therapy;Bioorganic Chemistry;2024-08

3. NAD+ Metabolism Reprogramming Mediates Irradiation-Induced Immunosuppressive Polarization of Macrophages;International Journal of Radiation Oncology*Biology*Physics;2024-08

4. Targeting NAD Metabolism: Rational Design, Synthesis and In Vitro Evaluation of NAMPT/PARP1 Dual-Target Inhibitors as Anti-Breast Cancer Agents;Molecules;2024-06-14

5. Discovery of Novel Dual Inhibitors Targeting Mutant IDH1 and NAMPT for the Treatment of Glioma with IDH1Mutation;Journal of Medicinal Chemistry;2024-04-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3